BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11377424)

  • 1. Actomyosin cross-linking by caldesmon in non-muscle cells.
    Goncharova EA; Shirinsky VP; Shevelev AY; Marston SB; Vorotnikov AV
    FEBS Lett; 2001 May; 497(2-3):113-7. PubMed ID: 11377424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of caldesmon in the regulation of endothelial cytoskeleton and migration.
    Mirzapoiazova T; Kolosova IA; Romer L; Garcia JG; Verin AD
    J Cell Physiol; 2005 Jun; 203(3):520-8. PubMed ID: 15521070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modes of caldesmon binding to actin: sites of caldesmon contact and modulation of interactions by phosphorylation.
    Foster DB; Huang R; Hatch V; Craig R; Graceffa P; Lehman W; Wang CL
    J Biol Chem; 2004 Dec; 279(51):53387-94. PubMed ID: 15456752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caldesmon and a 20-kDa actin-binding fragment of caldesmon inhibit tension development in skinned gizzard muscle fiber bundles.
    Pfitzer G; Zeugner C; Troschka M; Chalovich JM
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):5904-8. PubMed ID: 8327461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Location and functional characterization of myosin contact sites in smooth muscle caldesmon.
    Vorotnikov AV; Marston SB; Huber PA
    Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):211-8. PubMed ID: 9359855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of phosphorylation of smooth-muscle caldesmon.
    Ngai PK; Walsh MP
    Biochem J; 1987 Jun; 244(2):417-25. PubMed ID: 2822003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caldesmon, N-terminal yeast actin mutants, and the regulation of actomyosin interactions.
    Crosbie RH; Miller C; Chalovich JM; Rubenstein PA; Reisler E
    Biochemistry; 1994 Mar; 33(11):3210-6. PubMed ID: 8136356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of the ATP-dependent interaction between actin and myosin by a myosin-binding fragment of smooth muscle caldesmon.
    Lin Y; Ishikawa R; Okagaki T; Ye LH; Kohama K
    Cell Motil Cytoskeleton; 1994; 29(3):250-8. PubMed ID: 7895289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some properties of caldesmon and calponin and the participation of these proteins in regulation of smooth muscle contraction and cytoskeleton formation.
    Gusev NB
    Biochemistry (Mosc); 2001 Oct; 66(10):1112-21. PubMed ID: 11736632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of mitotically phosphorylated caldesmon.
    Yamakita Y; Yamashiro S; Matsumura F
    J Biol Chem; 1992 Jun; 267(17):12022-9. PubMed ID: 1534804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural study of gizzard caldesmon and its interaction with actin. Binding involves residues of actin also recognised by myosin subfragment 1.
    Levine BA; Moir AJ; Audemard E; Mornet D; Patchell VB; Perry SV
    Eur J Biochem; 1990 Nov; 193(3):687-96. PubMed ID: 2147415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a caldesmon fragment that competes with myosin-ATP binding to actin.
    Velaz L; Chen YD; Chalovich JM
    Biophys J; 1993 Aug; 65(2):892-8. PubMed ID: 8218912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of caldesmon to smooth muscle myosin.
    Ikebe M; Reardon S
    J Biol Chem; 1988 Mar; 263(7):3055-8. PubMed ID: 3257755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity studies of the regulatory interaction of the 10 kilodalton C-terminal fragment of caldesmon with actin and the effect of mutation of caldesmon residues 691-696.
    Huber PA; Gao Y; Fraser ID; Copeland O; EL-Mezgueldi M; Slatter DA; Keane NE; Marston SB; Levine BA
    Biochemistry; 1998 Feb; 37(8):2314-26. PubMed ID: 9485378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the effects of calponin on smooth and skeletal muscle actomyosin systems in the presence and absence of caldesmon.
    Winder SJ; Sutherland C; Walsh MP
    Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):733-9. PubMed ID: 1471986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of caldesmon prevents its interaction with smooth muscle myosin.
    Sutherland C; Walsh MP
    J Biol Chem; 1989 Jan; 264(1):578-83. PubMed ID: 2909541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitory complex of smooth muscle caldesmon with actin and tropomyosin involves three interacting segments of the C-terminal domain 4.
    Fraser ID; Copeland O; Bing W; Marston SB
    Biochemistry; 1997 May; 36(18):5483-92. PubMed ID: 9154931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of calponin and a 38-kDa caldesmon fragment on formation of the "strong-binding" state in ghost muscle fibers.
    Borovikov YS; Khoroshev MI; Chacko S
    Biochem Biophys Res Commun; 1996 Jun; 223(2):240-4. PubMed ID: 8670266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caldesmon is an integral component of podosomes in smooth muscle cells.
    Eves R; Webb BA; Zhou S; Mak AS
    J Cell Sci; 2006 May; 119(Pt 9):1691-702. PubMed ID: 16595550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of high-Mr caldesmon by protein kinase C modulates the regulatory function of this protein on the interaction between actin and myosin.
    Tanaka T; Ohta H; Kanda K; Tanaka T; Hidaka H; Sobue K
    Eur J Biochem; 1990 Mar; 188(3):495-500. PubMed ID: 2139605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.